OLDW commercial includes people with both medical and prescription coverage; excludes people with unknown race/ethnicity, year of birth, or sex Source: CPS ASEC (Current Population Survey-Annual Social and Economic Supplement), data for 2015, using https://www.census.gov/cps/data/cpstablecreator.html; Includes only people listed with a single race. Hispanic includes people of any single race who indicated they were of Hispanic origin Data sharing: OptumLabs data are deidentified and available for research through a virtual data warehouse. OptumLabs has agreed to make the dataset for this study and the accompanying code available to interested researchers interested in replicating the findings through a virtual data warehouse. Interested researchers can contact the corresponding author for the manuscript and the author will facilitate access to the data and code for the researchers.
Appendix 3:
Opioid drugs included/excluded; MME conversion factors
We identified all opioid drugs present in the table of NDC codes in OptumLabs Data Warehouse. For the purposes of this analysis, we classified tramadol as an opioid. We excluded DEA schedule 5 drugs (e.g., codeine cough syrups).
To limit the sample to drugs intended for home use, we excluded any injected or infused drug-those for which the dosage form was vial, syringe, ampule, cartridge, IV solution, etc. We included only drugs which had a defined dose unit like a tablet, pill, mg/mL, etc. This excludes drugs in powder or bulk form. We included both single drug formulations and combinations of drugs. Table A1 includes all opioid drug combinations found in the table of NDC codes. Both long-acting and short-acting formulations were included.
Conversion factors were taken from the CDC compilation 1 except for propoxyphene. The CDC uses a single conversion factor for all propoxyphene salts. However, according to the drug monograph, propoxyphene napsylate and propoxyphene hydrochloride have different doses for the same effect due to differences in the weight of the molecule. According to the monograph, a 65mg dose of the hydrochloride is equivalent to a 100mg dose of the napsylate.
2 The 0.23 conversion factor given for propoxyphene in the CDC compilation applies to the HCl salt: 130 mg propoxyphene HCl=30 mg morphine. With 65mg propoxyphene HCl=100mg propoxyphene napsylate, this implies a conversion factor to morphine of 0.15 for the napsylate, which is what we have used in the paper. Since the napsylate was far more common than the hydrochloride, this ends up being conservative relative to the CDC conversion factors-in other words, it reduces the total estimated MME of propoxyphene dispensed. 
